MedPath

A randomized controlled study of wearable devices combined with Baduanjin in the management of movement in metabolic syndrome

Phase 1
Conditions
Metabolic syndrome
Registration Number
ITMCTR2200005860
Lead Sponsor
Guangdong Provincial Hospital of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

?Age between 18 and 70 years old.
?Patients in the outpatient clinic and ward of the Department of Endocrinology of Guangdong Provincial Hospital of Traditional Chinese Medicine.
?Patients who meet the diagnosis of metabolic syndrome; and BMI = 24 kg/m2 .
?Those who signed the informed consent form.

Exclusion Criteria

? Severe cardiac, hepatic and renal insufficiency (blood creatinine clearance <30 ml/min, alanine aminotransferase =2.5 times the upper limit of normal, total bilirubin =1.5 times the upper limit of normal; chronic cardiac insufficiency, cardiac function class III and above).
?Those who are not suitable for exercise such as severe myocardial ischemia, severe hypertensive disease and unstable blood sugar.
?Those who cannot cooperate with exercise such as post-stroke, joint and muscle diseases, lumbar spine diseases, etc.
?Secondary lipid, blood pressure and glucose abnormalities.
?Type 1 diabetes.
?Hyperthyroidism or hypothyroidism.
?Taking weight-impacting drugs such as glucocorticoids, birth control pills and diet pills.
?Those who cannot understand the content of the study and have difficulty accepting the research protocol.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
HOMA-IR;
Secondary Outcome Measures
NameTimeMethod
BMI;Blood glucose;TCM symptom score;Exercise adherence;Blood pressure;EQ-5D health index scale;Body fat rate;Blood fat;
© Copyright 2025. All Rights Reserved by MedPath